Key Outcome of PoNS Stroke Research
Brooks Rehabilitation helped lead a multicenter clinical trial of the Portable Neuromodulation Stimulator (PoNS). The study supported FDA authorization for adults with chronic stroke symptoms that affect their ability to walk.
PoNS is a small device worn on the tongue during therapy. It delivers gentle electrical stimulation while patients practice balance and walking exercises. Brooks helped develop the study protocol and served as a multicenter clinical trial site.
- Industry partner: Mobia Medical, Inc. (formerly MicroTransponder, Inc)
- Brooks’ contribution: Clinical trial site, stroke rehabilitation expertise
- Research outcome: Supported FDA approval for chronic ischemic stroke
- Technology: Vivistim Paired VNS System
Quick snapshot: Vivistim therapy for stroke
Challenge
Many people continue to have trouble with balance and walking months or years after a stroke.
Solution
Evaluate whether adding PoNS to supervised physical therapy improves patient outcomes.
Brooks’ role
- Helped develop the clinical trial protocol
- Served as a multicenter clinical trial site to study PoNS for chronic stroke
- Evaluated how the technology performed in a real rehabilitation setting
Result
The study supported FDA authorization of PoNS for adults with chronic stroke symptoms that affect walking. The PoNS device can be used in patients aged 22 and older as a supplement to therapeutic exercise by prescription only.
Clinical background + objective
Brooks helped evaluate PoNS therapy for people recovering from stroke. The PoNS device was first authorized for people with multiple sclerosis (MS). Brooks partnered with the device manufacturer, Helius Medical Technologies, to study whether the device could also help stroke survivors. Bioness later acquired the PoNS technology.
Brooks designed a rehabilitation protocol that integrated PoNS into evidence-based physical therapy for stroke. This ensured the technology was evaluated in a way that reflected real clinical practice.
Researchers designed the study around one important question: Can PoNS make quality physical therapy for stroke even more effective?
Researchers chose to compare physical therapy with the addition of PoNS to physical therapy alone. This approach measured whether the device added value to proven rehabilitation techniques.
Patient population
The study included adults with chronic stroke who continued to have issues with balance and walking.
Researchers enrolled 159 adults with these criteria across multiple clinical sites. Of those, 130 completed the treatment program and follow-up.
Intervention
PoNS sends gentle electrical signals to nerves connected to areas of the brain that help control balance and walking. The stimulation helps the brain respond more effectively while patients practice their physical therapy. Participants wore the device while completing therapist-guided balance and walking exercises.
They completed a 12-week rehabilitation program. Everyone received physical therapy from experienced therapists. Half of the participants used an active PoNS device. The other half used a placebo device that looked and felt the same but did not deliver stimulation.
This study design helped researchers determine whether PoNS improved outcomes beyond physical therapy alone.
Unlike some other rehabilitation technologies, PoNS is:
- Designed to fit into existing rehabilitation programs
- Easy to use during therapy
- Lightweight
- Portable
Clinical insights + results
Participants who used PoNS showed greater improvements in dynamic balance during walking than those using the comparison device. Better balance may help people walk more safely, reduce falls and feel more confident during everyday activities.
The findings led the FDA to authorize PoNS as an addition to supervised physical therapy for adults with chronic stroke symptoms that affect their ability to walk. The FDA indication now states that PoNS may be used as an add-on to a supervised therapeutic exercise program for adults aged 22 and older with chronic stroke symptoms that affect walking.
“It’s very rewarding to get state-of-the-art equipment into the hands of therapists while also knowing how well it works and how to best use it in order to help our patients achieve better outcomes.”
Mark Bowden, PT, PhD
Vice President of Clinical Integration and Research
Brooks Rehabilitation
Brooks Rehabilitation has long been an early adopter of rehabilitation technology. Through the Brooks Center for Innovation, Brooks partners with researchers and industry-leading companies to help develop, test and improve promising new rehabilitation innovations before they reach patients. This work helps ensure new technology is supported by clinical evidence before it becomes part of everyday rehabilitation programs across the nation.
Working together, researchers and clinicians can determine:
- Whether a technology improves patient outcomes
- Which patients benefit most
- How therapists should use the technology in practice
Connect with Brooks
Interested in partnering with the Brooks Center for Innovation? Connect with our team to learn how we evaluate emerging rehabilitation technology and bring evidence-based innovations into patient care.